Cardiovascular compositions

A composition and cardiovascular technology, applied in the direction of cardiovascular system diseases, drug combinations, active ingredients of heterocyclic compounds, etc.

Inactive Publication Date: 2008-02-13
药物技术公司
View PDF4 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Conventional nutritional supplements often provide only one ingredient for promoting cardiovascular health

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cardiovascular compositions

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Embodiment 1-The preparation method of composition of the present invention

[0039] 391.5 Kg of fish oil (850 mg / g omega-3 fatty acids) was dispensed in the mixing tank and mixed at 725±50 revolutions per minute (rpm). The mixture was heated to 45°C ± 2°C. Stirring was continued and 38 Kg of silica was added. The resulting mixture was heated to 50°C and 14 Kg of unbleached lecithin NF was added slowly. Continue mixing at 725±50 rpm until the mixture cools to 34°C±2°C. While keeping the temperature below 37°C, slowly add the following with constant stirring: Vitamin B 6 - Pyridoxine Hydrochloride USP 11.25Kg, Folic Acid 0.975 Kg, Omega-3 Fatty Acid Powder (188.4mg / g) 429 Kg and Vitamin E Succinate 75Kg. To promote powder wetting, gradually increase mixing speed during powder addition. To ensure complete wetting and dispersion of the powder, scrape the walls of the tank to prevent accumulation of loose fill material. The rotation speed was adjusted to provide suff...

Embodiment 2

[0040] Example 2 - Composition Dosage of the Invention

[0041] The doses of the composition of the invention are provided in the form of two gel capsules of different formulations as shown in Table 1 below:

[0042] Table 1

[0043] Capsule 1

Embodiment 3

[0044] Example 3 - Composition Dosage of the Invention

[0045] Doses of the composition of the present invention are provided in the form of a tablet and a gel capsule of different formulations as shown in Table 2 below:

[0046] Table 2

[0047] tablet

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Compositions that promote and / or maintain cardiovascular health through the treatment of one or more cardiovascular diseases are provided. Also provided are methods for using compositions that promote and / or maintain cardiovascular health through the prevention, stabilization, reversal and / or treatment of coronary artery disease and / or cerebrovascular disease. Such compositions may be used independently to promote and / or maintain cardiovascular health or used in combination with one or more other compositions used in the treatment of various other disease states common to aging and / or a health deteriorating condition.

Description

technical field [0001] The present invention relates to compositions for promoting and / or maintaining cardiovascular health by treating one or more cardiovascular diseases. More specifically, the present invention relates to compositions for promoting and / or maintaining cardiovascular health by preventing, stabilizing, reversing and / or treating coronary artery disease and / or cerebrovascular disease. The compositions of the present invention may be used alone to promote and / or maintain cardiovascular health or in combination with one or more other compositions for the treatment of various other diseases often resulting from aging or deteriorating health conditions. Background technique [0002] Cardiovascular disease remains a leading cause of death in countries around the world. An estimated 30 million Americans suffer from some form of cardiovascular disease. Among these 30 million people, more than 4 million people have obvious clinical symptoms of atherosclerosis, mainl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/525A61K31/44A61K31/355A61K31/34A61K31/22
CPCA61K31/525A61K31/202A61K45/06A61K31/355A61K31/4415A61K31/375A61P1/02A61P9/00A61P9/10A61K2300/00
Inventor J·D·伯茨M·I·基施纳M·S·赫尔梅林D·S·赫尔梅林
Owner 药物技术公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap